Oral BPC-157 Protocol 2026: Complete No-Injection Guide

Week 1: 500mcg once daily, fasted, morning. Week 2–4: 500mcg twice daily (morning fasted + evening 2h post-meal). Week 5–6: 1mg once daily if response is good. Assess after 6 weeks. Take 2 weeks off, then repeat if needed. Track symptoms weekly—most gut improvements become noticeable by week 2–3.

Yes. Many users buy lyophilized BPC-157 powder in bulk and fill capsules using a capsule machine and empty gelatin or HPMC capsules. This is cost-effective and lets you control dose precisely. Use a 0.1mg-accurate milligram scale. Store filled capsules in a dark, cool, dry environment. Powder in capsules has a shorter functional shelf life than intact lyophilized vials.

Sublingual BPC-157 (dissolved in water and held under the tongue for 60–90 seconds before swallowing) is used by some practitioners as a potentially faster-absorbing alternative to capsules. The sublingual mucosa bypasses first-pass metabolism. No formal bioavailability data exists for this route. Intranasal BPC-157 is a separate route with some research interest, particularly for neurological applications.

Track subjective markers weekly: gut bloating, bowel regularity, pain level at injured site (score 1–10), energy, and sleep quality. Most users notice gut improvements (less bloating, better regularity) within 7–14 days. Tendon/joint pain reduction typically becomes noticeable at week 2–4. Take dated baseline notes before starting so changes are trackable rather than impressionistic.